Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
46 drugs in development
By Therapeutic Area
top 6
R&D Momentum
99/100
Pipeline Velocity
80/100
Trial Completion Rate
72/100
Pipeline Concentration
9/100
Pipeline Freshness
51/100
Strategic Signals
Activity
Last 14 days
Effects of Resistance Exercise Among TGD Individuals Initiating Estrogen-Based Gender-Affirming Hormone Therapy
A Prospective, Randomized, Open-Label Study to Examine The Effects of a Pressure-Enabled Drug Delivery Device on Radiotracer Distribution Compared to a Standard Microcatheter in the Context of Radioembolization
Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening
Impact of Sex and Age on Non-visual Light Input That Affects Sleep and Circadian Rhythms
Study to Determine the Clinical Significance of Intravascular OCT-NIRAF
Screening for Edema and Breast Cancer-Related Lymphedema in Patients Undergoing Targeted Therapy for Breast Cancer
Study for Imaging the Lower Gastrointestinal Tract Using a Colonoscopy-Compatible OCT Probe
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)